StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
908
This year
301
Publishing Date
2023 - 09 - 25
4
2023 - 09 - 18
5
2023 - 07 - 27
6
2023 - 07 - 26
6
2023 - 05 - 19
6
2023 - 05 - 15
6
2023 - 04 - 13
5
2023 - 04 - 12
6
2023 - 04 - 11
5
2023 - 02 - 13
5
2023 - 01 - 24
5
2022 - 12 - 06
4
2022 - 11 - 23
4
2022 - 10 - 20
4
2022 - 09 - 29
4
2022 - 09 - 26
4
2022 - 09 - 19
5
2022 - 08 - 17
4
2022 - 08 - 02
4
2022 - 06 - 17
5
2022 - 05 - 16
4
2022 - 04 - 28
7
2022 - 04 - 13
5
2022 - 04 - 12
4
2022 - 04 - 08
4
2022 - 03 - 16
4
2022 - 03 - 10
4
2022 - 03 - 08
4
2022 - 03 - 01
5
2022 - 02 - 18
3
2022 - 02 - 17
4
2022 - 01 - 05
3
2021 - 12 - 14
4
2021 - 12 - 13
3
2021 - 12 - 06
3
2021 - 11 - 15
3
2021 - 11 - 04
4
2021 - 11 - 01
4
2021 - 10 - 29
4
2021 - 10 - 07
3
2021 - 09 - 16
4
2021 - 09 - 03
3
2021 - 08 - 18
3
2021 - 08 - 11
3
2021 - 08 - 09
3
2021 - 07 - 29
3
2021 - 07 - 23
3
2021 - 07 - 08
4
2021 - 06 - 29
3
2021 - 06 - 11
4
2021 - 06 - 09
5
2021 - 06 - 04
5
2021 - 06 - 03
3
2021 - 05 - 24
4
2021 - 05 - 12
3
2021 - 05 - 10
3
2021 - 04 - 23
3
2021 - 04 - 07
4
2021 - 04 - 05
3
2021 - 04 - 02
3
Sector
Commercial services
7
Communications
10
Consumer durables
2
Consumer non-durables
11
Distribution services
2
Electronic technology
19
Energy minerals
4
Finance
15
Finance and insurance
3
Health care and social assistance
1
Health services
3
Health technology
908
Industrial services
4
Information
2
Manufacturing
112
Mining, quarrying, and oil and gas extraction
2
Miscellaneous
1
N/a
43
Non-energy minerals
3
Process industries
14
Producer manufacturing
15
Professional, scientific, and technical services
5
Retail trade
4
Technology services
14
Utilities
3
Tags
Abbvie
52
Active
13
Aesthetic
21
Alliances
18
America
36
Antibody
10
Application
14
Approval
36
Atopic dermatitis
10
Biomidwest
39
Bioscience
9
Biotech-beach
10
Business
9
Cancer
47
Cd20
11
Chmp
10
Clinical-trials-phase-iii
25
Collaboration
20
Conference
27
Contraceptive
9
Contract
11
Deadline
17
Dermatitis
13
Disease
60
Drug
66
Duobody
11
Earnings
21
Europe
15
Events
22
Expected
15
Eye
16
Fda
41
Financial
21
Financial results
12
Genetown
11
Global
87
Growing
22
Growth
151
Health
18
Leukemia
14
Market
311
Meeting
10
Migraine
22
N/a
679
Pharma
17
Phase 3
30
Positive
29
Reach
11
Report
78
Research
68
Results
75
Rinvoq
27
Risankizumab
14
Set
9
Skyrizi
16
Therapeutics
68
Therapy
38
Treatment
112
Trial
30
Ulcerative colitis
14
Entities
3m company
868
Abb ltd
1301
Abbott laboratories
1543
Abbvie inc.
908
Accenture plc
540
Alphabet inc.
1101
Amgen inc.
694
Apple inc.
1091
Arcelormittal
500
Arrival
3798
Astrazeneca plc
587
Athena consumer acquisition corp.
523
Becton, dickinson and company
722
Bnp paribas
1628
Boston scientific corporation
524
Bristol-myers squibb company
596
Broadcom inc.
521
Cisco systems, inc.
808
Danaher corporation
724
Dell technologies inc.
516
Dow inc.
521
Eli lilly and company
1546
Ericsson
1459
Extreme networks, inc.
581
First bank
557
Ford motor company
564
Gartner, inc.
523
General electric company
851
Glaxosmithkline plc
825
Honeywell international inc.
1612
Hubspot, inc.
1290
Intel corporation
874
International business machines corporation
604
Johnson & johnson
3972
Kering
1005
Koninklijke philips n.v.
884
Lithium corp
869
Live nation entertainment, inc.
717
Lockheed martin corporation
519
Medtronic plc
1192
Microsoft corporation
1126
Morgan stanley
3637
Nokia corp
884
Nokia corporation
824
Northrop grumman corporation
532
Novartis ag
1108
Novo nordisk a/s
566
Oracle corporation
1080
Orange
6070
Panasonic corp
590
Pfizer, inc.
642
Sanofi
3985
Sap se
1377
Snowflake inc.
705
Teva pharmaceutical industries ltd
564
Thermo fisher scientific inc
1427
Total se
1577
Verizon communications inc.
1056
Vision sensing acquisition corp.
498
X financial
562
Symbols
ABBV
908
ABT
51
ADCT
9
AGIO
12
ALC
13
ALNY
11
ALPMF
36
ALPMY
36
ALXN
17
AMGN
137
ANIK
9
AVEO
10
AZN
78
AZNCF
68
BAX
22
BCRX
13
BGNE
11
BHC
55
BIIB
31
BMY
74
BPMC
11
CHRS
36
CLVS
10
ENDP
11
EPZM
10
EXEL
11
GILD
36
GLAXF
119
GMAB
24
GNMSF
20
GSK
135
ILMN
11
INCY
16
IRWD
12
JNJ
139
KPTI
12
LLY
94
MDT
18
MYL
14
NEOS
13
NVO
12
NVS
200
NVSEF
179
OMER
13
OTIC
13
PFE
36
REGN
20
RIGL
10
SNY
175
SNYNF
131
TAK
25
TEVA
10
TEVJF
108
TMO
27
UCBJF
12
UCBJY
12
VSTM
10
VTRS
61
XERS
11
YMAB
10
Exchanges
Amex
2
Lse
26
Nasdaq
535
Nyse
908
Tsx
12
Crawled Date
2023 - 11 - 01
4
2023 - 09 - 18
5
2023 - 07 - 27
6
2023 - 07 - 26
6
2023 - 05 - 19
5
2023 - 05 - 15
6
2023 - 04 - 13
5
2023 - 04 - 12
6
2023 - 04 - 11
5
2023 - 02 - 13
4
2023 - 01 - 24
5
2023 - 01 - 10
4
2022 - 12 - 15
4
2022 - 12 - 06
4
2022 - 11 - 23
4
2022 - 10 - 20
4
2022 - 09 - 27
4
2022 - 09 - 19
5
2022 - 08 - 17
4
2022 - 08 - 02
5
2022 - 06 - 17
5
2022 - 05 - 16
4
2022 - 04 - 28
7
2022 - 04 - 13
5
2022 - 04 - 12
4
2022 - 04 - 08
5
2022 - 03 - 16
4
2022 - 03 - 08
4
2022 - 03 - 01
4
2022 - 02 - 17
4
2022 - 01 - 05
3
2021 - 12 - 14
3
2021 - 12 - 13
3
2021 - 12 - 06
3
2021 - 11 - 15
3
2021 - 11 - 05
3
2021 - 11 - 04
3
2021 - 11 - 01
4
2021 - 10 - 29
4
2021 - 10 - 07
3
2021 - 09 - 16
4
2021 - 09 - 03
3
2021 - 08 - 18
3
2021 - 08 - 11
3
2021 - 08 - 09
3
2021 - 07 - 29
3
2021 - 07 - 27
3
2021 - 07 - 08
4
2021 - 06 - 29
3
2021 - 06 - 11
4
2021 - 06 - 09
5
2021 - 06 - 04
5
2021 - 06 - 03
3
2021 - 05 - 24
3
2021 - 05 - 12
3
2021 - 05 - 10
3
2021 - 04 - 23
3
2021 - 04 - 07
4
2021 - 04 - 05
3
2021 - 04 - 02
3
Crawled Time
00:00
34
00:20
5
01:00
27
01:10
1
02:00
20
03:00
20
04:00
17
04:20
7
05:00
9
06:00
17
07:00
24
08:00
21
08:20
1
09:00
19
10:00
15
10:10
1
10:51
1
11:00
39
12:00
54
12:15
10
12:20
15
12:30
3
12:34
1
13:00
51
13:07
3
13:13
1
13:15
10
13:17
1
13:20
12
13:27
1
13:30
14
13:50
1
14:00
50
14:03
1
14:04
1
14:07
1
14:12
1
14:15
7
14:20
10
14:30
11
15:00
46
15:11
1
15:15
7
15:20
10
15:30
9
15:49
1
16:00
46
16:20
7
17:00
34
17:37
1
17:43
1
18:00
30
18:04
1
18:31
2
19:00
29
20:00
41
20:20
6
21:00
26
22:00
32
23:00
34
Source
beamforall.com
1
investor.assemblybio.com
2
www.biospace.com
229
www.fda.gov
24
www.globenewswire.com
68
www.jupiterwellnessinc.com
1
www.prnewswire.com
582
www.vermillion.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Abbvie inc.
save search
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
Published:
2023-11-30
(Crawled : 15:30)
- biospace.com/
MS
|
News
3 d
|
$80.89
1.95%
0.05%
9.6M
|
Finance
|
0.65%
|
O:
0.28%
H:
0.9%
C:
0.72%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.81%
|
O:
-0.35%
H:
3.4%
C:
3.17%
IMGN
M
|
$29.32
82.57%
-0.75%
30M
|
Health Technology
|
81.82%
|
O:
81.82%
H:
0.0%
C:
0.0%
elahere
abbvie
cancer
tumor
acquire
therapy
AbbVie Announces Positive Topline Results from Phase 2 LUMINOSITY Trial Evaluating Telisotuzumab-Vedotin (Teliso-V) for Patients with Previously Treated Non-Small Cell Lung Cancer (NSCLC)
Published:
2023-11-29
(Crawled : 14:30)
- biospace.com/
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.42%
|
O:
-0.73%
H:
0.78%
C:
0.35%
lung
abbvie
positive
cancer
cell
topline
trial
results
CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023
Published:
2023-11-29
(Crawled : 12:00)
- prnewswire.com
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.42%
|
O:
-0.73%
H:
0.78%
C:
0.35%
CLGN
|
$5.35
-2.37%
1.68%
19K
|
Health Technology
|
-4.86%
|
O:
-3.82%
H:
4.15%
C:
-3.43%
biotechnologies
financial
results
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides Business Update
Published:
2023-11-28
(Crawled : 21:00)
- globenewswire.com
ALVO
|
$9.45
-0.53%
-0.42%
180K
|
n/a
|
-4.04%
|
O:
0.0%
H:
0.0%
C:
-5.05%
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
3.36%
|
O:
-0.04%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.42%
|
O:
-0.73%
H:
0.78%
C:
0.35%
KMDA
|
$4.65
-1.69%
0.0%
9.6K
|
Health Technology
|
-1.15%
|
O:
0.73%
H:
0.0%
C:
-1.04%
business
update
financial
results
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
Published:
2023-11-28
(Crawled : 21:00)
- globenewswire.com
ALVO
|
$9.45
-0.53%
-0.42%
180K
|
n/a
|
-4.04%
|
O:
0.0%
H:
0.0%
C:
-5.05%
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
3.36%
|
O:
-0.04%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.42%
|
O:
-0.73%
H:
0.78%
C:
0.35%
KMDA
|
$4.65
-1.69%
0.0%
9.6K
|
Health Technology
|
-1.15%
|
O:
0.73%
H:
0.0%
C:
-1.04%
business
update
financial
results
Open-Angle Glaucoma Therapeutics Market size to grow by USD 2.36 billion from 2022 to 2027, North America to account for 51% of market growth - Technavio
Published:
2023-11-28
(Crawled : 06:00)
- prnewswire.com
NVS
|
$98.13
0.24%
-0.16%
1.2M
|
Health Technology
|
-0.23%
|
O:
-0.74%
H:
0.08%
C:
-0.22%
BHC
|
$7.36
3.08%
0.0%
1.8M
|
Health Technology
|
5.86%
|
O:
1.48%
H:
1.17%
C:
0.29%
ALC
|
$75.85
0.29%
0.0%
970K
|
Health Technology
|
2.0%
|
O:
-0.75%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.62%
|
O:
0.19%
H:
0.0%
C:
0.0%
america
glaucoma
therapeutics
growth
market
AbbVie Announces U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) Updates for Epcoritamab (EPKINLY®/TEPKINLY®) for the Treatment of Relapsed/Refractory Follicular Lymphoma
Published:
2023-11-27
(Crawled : 12:00)
- prnewswire.com
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.35%
|
O:
-0.26%
H:
0.0%
C:
0.0%
epkinly
drug
abbvie
food
treatment
Global Pain Management Drugs and Devices Market Report 2023 - Focus on Key Players in Pain Management: Abbott Laboratories, AbbVie, Novartis and More
Published:
2023-11-24
(Crawled : 23:00)
- prnewswire.com
ABT
|
$104.88
0.57%
-0.01%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
management
report
global
novartis
market
HIV Drugs Market to Reach $51.1 Billion, Globally, by 2032 at 4.5% CAGR: Allied Market Research
Published:
2023-11-17
(Crawled : 16:00)
- prnewswire.com
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
4.67%
|
O:
0.78%
H:
0.0%
C:
0.0%
BMY
P
|
$50.1
1.46%
0.26%
11M
|
Health Technology
|
-2.87%
|
O:
0.67%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.97%
|
O:
0.01%
H:
0.0%
C:
0.0%
GILD
|
$77.65
1.37%
-0.05%
5.4M
|
Health Technology
|
2.08%
|
O:
-0.13%
H:
0.0%
C:
0.0%
reach
research
hiv
market
United States Employment Screening Market Insights Report 2023: A $2+ Billion Industry in 2022 - Forecasts to 2027 - Importance of Social Media Gaining Traction
Published:
2023-11-16
(Crawled : 03:00)
- prnewswire.com
AZNCF
|
$125.0
-2.72%
8.8%
3.4K
|
Health Technology
|
2.67%
|
O:
-2.16%
H:
4.44%
C:
2.2%
TFX
M
|
$227.67
0.88%
0.0%
220K
|
Health Technology
|
7.58%
|
O:
1.76%
H:
1.16%
C:
0.07%
GE
|
$122.5
0.58%
0.16%
4.5M
|
Electronic Technology
|
4.1%
|
O:
-0.35%
H:
2.03%
C:
2.02%
BDX
S
|
$238.25
0.88%
0.37%
1.5M
|
Health Technology
|
0.94%
|
O:
0.48%
H:
0.84%
C:
0.18%
BAX
|
$36.55
1.3%
-0.08%
4.2M
|
Health Technology
|
5.54%
|
O:
2.67%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
3.26%
|
O:
0.28%
H:
0.39%
C:
0.0%
ABT
|
$104.88
0.57%
-0.01%
4.7M
|
Health Technology
|
6.93%
|
O:
0.5%
H:
0.0%
C:
0.0%
MMM
|
$99.85
0.79%
0.04%
2.8M
|
Producer Manufacturing
|
2.96%
|
O:
0.25%
H:
0.0%
C:
0.0%
ICUI
|
$91.34
4.08%
0.0%
480K
|
Health Technology
|
1.22%
|
O:
1.25%
H:
0.0%
C:
0.0%
AZN
|
$64.79
0.31%
0.03%
3.6M
|
Health Technology
|
1.69%
|
O:
-0.22%
H:
0.71%
C:
0.6%
media
report
market
Precision Medicine Market size to grow by 54.7 billion from 2022 to 2027- Technavio
Published:
2023-11-14
(Crawled : 23:00)
- prnewswire.com
AZNCF
|
$125.0
-2.72%
8.8%
3.4K
|
Health Technology
|
3.01%
|
O:
0.52%
H:
1.79%
C:
-0.19%
NVSEF
|
$97.95
1.48%
2.98%
100
|
Health Technology
|
5.2%
|
O:
1.25%
H:
0.0%
C:
-0.32%
TMO
|
$496.13
0.08%
0.0%
1.2M
|
Health Technology
|
7.91%
|
O:
1.67%
H:
0.0%
C:
0.0%
NVS
|
$98.13
0.24%
-0.16%
1.2M
|
Health Technology
|
3.26%
|
O:
-0.26%
H:
0.37%
C:
-0.6%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.49%
|
O:
-0.74%
H:
0.0%
C:
0.0%
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
1.82%
|
O:
-0.72%
H:
0.0%
C:
0.0%
AZN
|
$64.79
0.31%
0.03%
3.6M
|
Health Technology
|
0.54%
|
O:
-1.14%
H:
0.0%
C:
0.0%
market
Opioid Market Forecast: In-depth Analysis Predicts Continued Growth to $25.3 Billion by 2030
Published:
2023-11-14
(Crawled : 02:00)
- prnewswire.com
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
6.15%
|
O:
0.17%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.98%
|
O:
0.47%
H:
0.0%
C:
0.0%
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
2.51%
|
O:
0.68%
H:
0.0%
C:
0.0%
opioid
growth
market
Global Pharmaceutical Contract Manufacturing Market Report 2023-2030 with Competitive Analysis of Major Players - Overview, Financials, Product Portfolio, Key Developments, Business Strategy, SWOT
Published:
2023-11-14
(Crawled : 01:00)
- prnewswire.com
TMO
|
$496.13
0.08%
0.0%
1.2M
|
Health Technology
|
10.58%
|
O:
2.48%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.98%
|
O:
0.47%
H:
0.0%
C:
0.0%
report
business
contract
global
market
NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year
Published:
2023-11-13
(Crawled : 21:00)
- globenewswire.com
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.98%
|
O:
0.47%
H:
0.0%
C:
0.0%
revenue
Oncology Drugs Market worth $520 billion by 2033 - Exclusive Report by We Market Research
Published:
2023-11-10
(Crawled : 15:00)
- prnewswire.com
PFE
|
$28.91
-5.12%
0.0%
100M
|
Health Technology
|
-7.15%
|
O:
-4.83%
H:
0.0%
C:
0.0%
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
4.31%
|
O:
-1.24%
H:
0.0%
C:
0.0%
BMY
P
|
$50.1
1.46%
0.26%
11M
|
Health Technology
|
-5.89%
|
O:
-3.68%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
3.15%
|
O:
0.44%
H:
0.0%
C:
0.0%
AZN
|
$64.79
0.31%
0.03%
3.6M
|
Health Technology
|
-0.81%
|
O:
-2.88%
H:
0.0%
C:
0.0%
report
research
market
Mexico aesthetic devices market to grow by USD 533.06 million from 2023 to 2028- Technavio
Published:
2023-11-09
(Crawled : 23:00)
- prnewswire.com
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
3.15%
|
O:
0.44%
H:
0.0%
C:
0.0%
aesthetic
market
Trishula Therapeutics Initiates Phase 2 Trial of TTX-030, an Anti-CD39 Antibody, in First Line Metastatic Pancreatic Cancer Patients
Published:
2023-11-09
(Crawled : 14:00)
- biospace.com/
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
-0.84%
|
O:
-1.81%
H:
0.43%
C:
-2.1%
ttx-030
cancer
pancreatic
trial
therapeutics
Ironwood Pharmaceuticals Reports Third Quarter 2023 Results
Published:
2023-11-09
(Crawled : 13:30)
- biospace.com/
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
-0.84%
|
O:
-1.81%
H:
0.43%
C:
-2.1%
IRWD
|
$10.3
4.04%
3.88%
2.3M
|
Health Technology
|
5.69%
|
O:
2.04%
H:
4.37%
C:
0.21%
pharmaceuticals
ironwood
results
Advanced Anesthesia Devices and Ambulatory Surgical Centers Propel Growth in the US Anesthesia Market
Published:
2023-11-07
(Crawled : 00:00)
- prnewswire.com
AZNCF
|
$125.0
-2.72%
8.8%
3.4K
|
Health Technology
|
2.59%
|
O:
-1.99%
H:
1.92%
C:
1.89%
TFX
M
|
$227.67
0.88%
0.0%
220K
|
Health Technology
|
8.58%
|
O:
-2.14%
H:
0.0%
C:
0.0%
KKR
|
$74.87
-1.28%
-1.18%
5.2M
|
Finance
|
27.25%
|
O:
5.05%
H:
0.28%
C:
-0.32%
GE
|
$122.5
0.58%
0.16%
4.5M
|
Electronic Technology
|
9.28%
|
O:
0.66%
H:
1.65%
C:
1.47%
BDX
S
|
$238.25
0.88%
0.37%
1.5M
|
Health Technology
|
-9.07%
|
O:
-0.64%
H:
0.0%
C:
-0.64%
BAX
|
$36.55
1.3%
-0.08%
4.2M
|
Health Technology
|
5.66%
|
O:
0.03%
H:
0.0%
C:
-1.19%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
0.7%
|
O:
1.55%
H:
0.0%
C:
0.0%
ABT
|
$104.88
0.57%
-0.01%
4.7M
|
Health Technology
|
9.5%
|
O:
0.04%
H:
0.54%
C:
-0.5%
MMM
|
$99.85
0.79%
0.04%
2.8M
|
Producer Manufacturing
|
6.21%
|
O:
0.69%
H:
0.0%
C:
0.0%
ICUI
|
$91.34
4.08%
0.0%
480K
|
Health Technology
|
-11.32%
|
O:
-15.97%
H:
4.7%
C:
4.21%
AZN
|
$64.79
0.31%
0.03%
3.6M
|
Health Technology
|
1.29%
|
O:
-0.06%
H:
0.64%
C:
-0.38%
propel
growth
market
Genmab Announces Financial Results for the First Nine Months of 2023
Published:
2023-11-07
(Crawled : 16:00)
- globenewswire.com
GNMSF
|
$314.475
-1.42%
-0.25%
860
|
Health Technology
|
11.81%
|
O:
0.39%
H:
4.92%
C:
1.52%
NVS
|
$98.13
0.24%
-0.16%
1.2M
|
Health Technology
|
4.69%
|
O:
0.38%
H:
0.18%
C:
0.16%
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
3.17%
|
O:
0.18%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
0.42%
|
O:
-0.28%
H:
0.0%
C:
0.0%
GMAB
|
$31.97
1.14%
-0.02%
680K
|
Health Technology
|
9.57%
|
O:
0.28%
H:
0.0%
C:
0.0%
BNTX
|
$99.4
-1.01%
-1.29%
800K
|
Health Technology
|
0.7%
|
O:
-1.4%
H:
0.0%
C:
0.0%
financial
results
← Previous
1
2
3
4
5
6
7
8
9
…
45
46
Next →
Gainers vs Losers
77%
23%
Top 10 Gainers
ID
4
|
$0.077
-9.41%
25.97%
420K
|
Finance
BKKT
4
|
$1.88
25.33%
14.89%
4.8M
|
MGLD
|
$1.03
7.77%
14K
|
Manufacturing
CZOO
|
$0.4316
-6.52%
6.7%
65K
|
SATX
|
$0.4226
-1.72%
6.48%
29K
|
n/a
CCJ
|
$45.4
-1.13%
4.6%
3.9M
|
Non-Energy Minerals
AUMN
|
$0.562
0.34%
4.5%
360K
|
Non-Energy Minerals
JBL
|
$116.91
1.38%
4.3%
2M
|
Electronic Technology
SAIC
4
|
$119.92
2.14%
4.24%
460K
|
Technology Services
CULP
4
|
$5.06
-0.59%
3.95%
29K
|
Process Industries
Your saved searches
Save your searches and get alerts when important news are released.